Home
About
Overview
Sharing Data
ORCID
Help
History (27)
USP22 Interacts with PALB2 and Promotes Chemotherapy Resistance via Homologous Recombination of DNA Double-Strand Breaks.
Ablative Radiotherapy as a Strategy to Overcome TKI Resistance in EGFR-Mutated NSCLC.
Role of Paxillin in Lung Cancer
New strategies in colon cancer adjuvant therapy.
Regression of ovarian cancer xenografts by depleting or inhibiting RLIP.
See All 27 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Regression of ovarian cancer xenografts by depleting or inhibiting RLIP.
Regression of ovarian cancer xenografts by depleting or inhibiting RLIP. Biochem Pharmacol. 2023 11; 217:115847.
View in:
PubMed
subject areas
Cell Line, Tumor
Cisplatin
Drug Resistance, Neoplasm
Female
Heterografts
Humans
Ovarian Neoplasms
Signal Transduction
authors with profiles
Ravi Salgia